Comparison of H2-receptor antagonist-and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in chinese patients with gastritis or peptic ulcer

Journal of International Medical Research

Volumn 31, Issue 6, 2003, Pages 469-474

  Hu, F L ^a   Jia, J C ^b   Li, Y L ^c   Yang, G B ^d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Luoyang Medical Training School   (China)

^c Central Hospital of Airline Industry   (China)

^d People's Hospital of Taojiang County   (China)

Author keywords

Amoxicillin; Eradication; Famotidine; Helicobacter pylori; Metronidazole; Omeprazone; Triple therapy

Indexed keywords

AMOXICILLIN; CARBON 13; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; UREASE; ANTIULCER AGENT; ENZYME INHIBITOR; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE;

ABDOMINAL DISTENSION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA; UREA BREATH TEST; ADOLESCENT; CHINA; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG COMBINATION; MICROBIOLOGY; MIDDLE AGED; PAIN; PATHOGENICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; CHINA; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FAMOTIDINE; FEMALE; GASTRITIS; H(+)-K(+)-EXCHANGING ATPASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PAIN; PEPTIC ULCER; TREATMENT OUTCOME;

EID: 0347519219     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100601     Document Type: Article

References (11)

1. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-1275.
2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
3. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Jr, Klein PD, et al: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-496.
4. Gschwantler M, Dragosics B, Schutze K, Wurzer H, Hirschl AM, Pasching E, et al: Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori - a randomized, controlled trial. Aliment Pharmacol Ther 1999; 13: 1063-1069.
5. 2-receptor antagonists in triple therapy for Helicobacter pylori eradication. Nippon Rinsho 1999; 57: 153-156.
6. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
7. Li Y-Y, Hu P-J, Chen H-H: Triple regimen of ranitidine, hydroxylamine benzyl penicillin and metronidazole is used for treatment of duodenal ulcer and eradication of Helicobacter pylori. Chin J Digestion 1997; 17: 174-175.
8. Gschwantler M, Dragosics B, Wurzer H, Brandstatter G, Weiss W: Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycin. Eur J Gastroenterol Hepatol 1998; 10: 579-582.
9. Zhang W-D, Xiao S-D, Hu F-L, Jia J-C, Li Y-L, Yang G-B: Common opinion about some questions of Helicobacter pylori. Natl Med J China 2000; 80: 394-395.
10. Savarino V, Zentilin P, Bisso G, Pivari M, Mele MR, Mela GS, et al: Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 643-649.
11. Hu F-L, Wang Z-G, Fan G-M. Comparison of 1 week and 2 weeks efficacy of lansoprazole triple therapy in treatment of H. pylori infection. Chin New Drugs J 1999; 8: 246-248.